Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide

Figure 1

Kaplan-Meier analysis of overall survival, disease-free survival, and nonrelapse mortality and following TBI-based MA haplo-HSCT.